Market RealistTrelegy Ellipta May Emerge as Major Growth Driver for GlaxoSmithKlineRead full articleMargaret PatrickUpdated 30 January 2018 at 4:26 pmTrelegy Ellipta May Emerge as Major Growth Driver for GlaxoSmithKlineA Look at GlaxoSmithKline's Growth Drivers in 2018FDA approval of Trelegy ElliptaContinue reading